You just read:

immatics Presents Positive Phase II Results With its Therapeutic Cancer Vaccine IMA910 in Patients With Advanced Colorectal Cancer at the 2012 ASCO Gastrointestinal Cancers Symposium

News provided by

immatics biotechnologies GmbH

24 Jan, 2012, 10:17 GMT